386PTP53 GOF mutations predict good response and prolonged survival to bevacizumab treatment in metastatic colorectal cancer
Hsieh, Y-L, Liu, Y, Lapke, N, Hsu, H-C, Chen, H-C, Chen, S-J, Tan, K TVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy441.019
Date:
November, 2018
File:
PDF, 72 KB
2018